Análisis opcionales del producto
Con tu permiso, usamos análisis limitados y respetuosos con la privacidad para entender qué recorridos de investigación funcionan. No usamos rastreadores publicitarios ni grabación de sesiones. Puedes cambiar esta opción en Preferencias. Lee la Política de privacidad.
The Procter & Gamble Company's published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $340.1B | |
|---|---|---|
| P/E (forward) | 21.1x |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | Trend |
| Revenue | $80.19B | $82.01B | $84.04B | $84.28B | $87.03B | +2.1% |
| Gross profit | $38.03B | $39.25B | $43.19B | $43.12B | $43.67B | +3.5% |
| Operating income | $17.81B | $18.13B | $18.55B | $20.45B | $19.75B | +2.6% |
| Net income | $14.74B | $14.65B | $14.88B | $15.97B | $16.05B | +2.1% |
| EPS (diluted) | $5.81 | $5.90 | $6.02 | $6.51 | $6.62 | +3.3% |
| EBITDA | $21.24B | $21.77B | $22.58B | $23.92B | $21.25B | +0.0% |
| R&D | $2.00B | $2.00B | $2.00B | $2.10B | $2.10B | +1.2% |
| SG&A | $20.22B | $21.11B | $23.31B | $22.67B | $23.92B | +4.3% |
Recent company headlines from major financial publishers.
The base case is modest compounding, not a sharp reacceleration. A miss against either annual revenue anchor would disconfirm it by FY2028.
Upside requires FY2028 earnings to meet the forecast, FY2026 cash generation to persist, and the FY2024-to-FY2026 decline in diluted shares to continue. A miss against the FY2028 forecast or weaker operating cash would disconfirm this path.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | $151 | $163 | $180 | $204 | $244 |
| 6.0% | $131 | $138 | $146 | $158 | $173 |
| 7.0% | $117 | $121 | $126 | $133 | $141 |
| 8.0% | $107 | $110 | $113 | $117 | $122 |
| 9.0% | $99.4 | $102 | $104 | $107 | $110 |
Upcoming earnings date and setup when available.
La calificación que llevaba la edición de análisis publicada cada mes. Una calificación compara el precio en la fecha del análisis con el valor razonable; no es un registro de si la valoración acertó.
| Año | ene | feb | mar | abr | may | jun | jul | ago | sept | oct | nov | dic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
